Annual EBIT
$164.88 M
+$8.85 M+5.67%
31 March 2024
Summary:
Haemonetics annual earnings before interest & taxes is currently $164.88 million, with the most recent change of +$8.85 million (+5.67%) on 31 March 2024. During the last 3 years, it has risen by +$75.14 million (+83.72%). HAE annual EBIT is now at all-time high.HAE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$51.70 M
+$11.94 M+30.04%
28 September 2024
Summary:
Haemonetics quarterly earnings before interest & taxes is currently $51.70 million, with the most recent change of +$11.94 million (+30.04%) on 28 September 2024. Over the past year, it has increased by +$16.39 million (+46.44%). HAE quarterly EBIT is now -12.05% below its all-time high of $58.78 million, reached on 26 September 2020.HAE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$167.37 M
+$16.39 M+10.86%
28 September 2024
Summary:
Haemonetics TTM earnings before interest & taxes is currently $167.37 million, with the most recent change of +$16.39 million (+10.86%) on 28 September 2024. Over the past year, it has dropped by -$122.00 thousand (-0.07%). HAE TTM EBIT is now -6.46% below its all-time high of $178.93 million, reached on 01 June 2023.HAE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.7% | +46.4% | -0.1% |
3 y3 years | +83.7% | +45.0% | +314.5% |
5 y5 years | +97.4% | +3.9% | +88.9% |
HAE EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +104.2% | -3.7% | +169.3% | -6.5% | +314.5% |
5 y | 5 years | at high | +104.2% | -12.1% | +344.1% | -6.5% | +314.5% |
alltime | all time | at high | +475.2% | -12.1% | +184.5% | -6.5% | +402.0% |
Haemonetics EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $51.70 M(+30.0%) | $167.37 M(+10.9%) |
June 2024 | - | $39.76 M(+32.8%) | $150.98 M(-8.4%) |
Mar 2024 | $164.88 M(+5.7%) | - | - |
Mar 2024 | - | $29.94 M(-34.9%) | $164.88 M(-3.1%) |
Dec 2023 | - | $45.98 M(+30.2%) | $170.19 M(+1.6%) |
Sept 2023 | - | $35.30 M(-34.2%) | $167.50 M(-6.4%) |
June 2023 | - | $53.66 M(+52.2%) | $178.93 M(+14.7%) |
Mar 2023 | $156.03 M(+93.2%) | $35.26 M(-18.5%) | $156.03 M(+11.5%) |
Dec 2022 | - | $43.28 M(-7.4%) | $139.98 M(+5.8%) |
Sept 2022 | - | $46.73 M(+51.9%) | $132.35 M(+20.2%) |
June 2022 | - | $30.77 M(+60.3%) | $110.13 M(+36.4%) |
Mar 2022 | $80.75 M(-10.0%) | $19.20 M(-46.1%) | $80.75 M(+100.0%) |
Dec 2021 | - | $35.65 M(+45.5%) | $40.38 M(-10.6%) |
Sept 2021 | - | $24.51 M(+1663.3%) | $45.15 M(-43.2%) |
June 2021 | - | $1.39 M(-106.6%) | $79.42 M(-11.5%) |
Mar 2021 | $89.75 M(-13.2%) | -$21.18 M(-152.4%) | $89.75 M(-34.5%) |
Dec 2020 | - | $40.42 M(-31.2%) | $136.93 M(-0.4%) |
Sept 2020 | - | $58.78 M(+401.8%) | $137.41 M(+7.0%) |
June 2020 | - | $11.71 M(-55.0%) | $128.37 M(+24.2%) |
Mar 2020 | $103.35 M(+23.7%) | $26.01 M(-36.4%) | $103.35 M(+2.1%) |
Dec 2019 | - | $40.91 M(-17.8%) | $101.20 M(+14.2%) |
Sept 2019 | - | $49.74 M(-473.9%) | $88.61 M(+36.4%) |
June 2019 | - | -$13.30 M(-155.8%) | $64.95 M(-22.3%) |
Mar 2019 | $83.55 M(+30.2%) | $23.86 M(-15.8%) | $83.55 M(+13.0%) |
Dec 2018 | - | $28.32 M(+8.6%) | $73.96 M(+58.5%) |
Sept 2018 | - | $26.08 M(+392.7%) | $46.66 M(+4.1%) |
June 2018 | - | $5.29 M(-62.9%) | $44.84 M(-30.1%) |
Mar 2018 | $64.16 M(-431.0%) | $14.28 M(+1309.2%) | $64.16 M(-941.5%) |
Dec 2017 | - | $1.01 M(-95.8%) | -$7.62 M(-160.6%) |
Sept 2017 | - | $24.26 M(-1.4%) | $12.57 M(-4.1%) |
June 2017 | - | $24.61 M(-142.8%) | $13.11 M(-167.6%) |
Mar 2017 | -$19.38 M(-55.9%) | -$57.51 M(-371.1%) | -$19.38 M(-159.5%) |
Dec 2016 | - | $21.21 M(-14.4%) | $32.58 M(-165.4%) |
Sept 2016 | - | $24.79 M(-414.6%) | -$49.81 M(-10.1%) |
June 2016 | - | -$7.88 M(+42.0%) | -$55.43 M(+26.1%) |
Mar 2016 | -$43.94 M(-202.0%) | -$5.55 M(-90.9%) | -$43.94 M(+80.6%) |
Dec 2015 | - | -$61.18 M(-419.0%) | -$24.33 M(-144.2%) |
Sept 2015 | - | $19.18 M(+431.9%) | $55.11 M(+14.0%) |
June 2015 | - | $3.61 M(-74.4%) | $48.33 M(+12.2%) |
Mar 2015 | $43.06 M(-10.6%) | $14.06 M(-23.0%) | $43.06 M(+1.3%) |
Dec 2014 | - | $18.26 M(+47.2%) | $42.51 M(+0.9%) |
Sept 2014 | - | $12.41 M(-844.7%) | $42.11 M(-20.7%) |
June 2014 | - | -$1.67 M(-112.3%) | $53.13 M(+10.3%) |
Mar 2014 | $48.19 M(-20.6%) | $13.51 M(-24.4%) | $48.19 M(-14.9%) |
Dec 2013 | - | $17.86 M(-23.8%) | $56.64 M(+3.9%) |
Sept 2013 | - | $23.43 M(-454.6%) | $54.52 M(+33.0%) |
June 2013 | - | -$6.61 M(-130.1%) | $40.99 M(-32.4%) |
Mar 2013 | $60.68 M(-30.4%) | $21.95 M(+39.4%) | $60.68 M(+1.7%) |
Dec 2012 | - | $15.75 M(+59.0%) | $59.69 M(-13.8%) |
Sept 2012 | - | $9.90 M(-24.3%) | $69.26 M(-11.1%) |
June 2012 | - | $13.08 M(-37.6%) | $77.93 M(-12.2%) |
Mar 2012 | $87.18 M(-19.8%) | $20.96 M(-17.2%) | $88.76 M(-6.4%) |
Dec 2011 | - | $25.32 M(+36.4%) | $94.80 M(-3.3%) |
Sept 2011 | - | $18.57 M(-22.3%) | $98.03 M(-9.5%) |
June 2011 | - | $23.91 M(-11.5%) | $108.37 M(-0.6%) |
Mar 2011 | $108.65 M(+32.5%) | $27.00 M(-5.5%) | $108.99 M(+26.9%) |
Dec 2010 | - | $28.56 M(-1.2%) | $85.90 M(+3.5%) |
Sept 2010 | - | $28.91 M(+17.8%) | $82.97 M(+3.2%) |
June 2010 | - | $24.53 M(+527.5%) | $80.39 M(-2.0%) |
Mar 2010 | $82.01 M(-3.6%) | $3.91 M(-84.7%) | $82.01 M(-15.0%) |
Dec 2009 | - | $25.63 M(-2.7%) | $96.47 M(+2.2%) |
Sept 2009 | - | $26.32 M(+0.7%) | $94.36 M(+3.0%) |
June 2009 | - | $26.15 M(+42.3%) | $91.64 M(+8.0%) |
Mar 2009 | $85.07 M(+21.0%) | $18.38 M(-21.8%) | $84.83 M(-2.2%) |
Dec 2008 | - | $23.51 M(-0.4%) | $86.75 M(+4.7%) |
Sept 2008 | - | $23.61 M(+22.1%) | $82.84 M(+12.2%) |
June 2008 | - | $19.33 M(-4.7%) | $73.84 M(+5.1%) |
Mar 2008 | $70.29 M | $20.30 M(+3.6%) | $70.29 M(-6.9%) |
Dec 2007 | - | $19.60 M(+34.1%) | $75.46 M(+3.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2007 | - | $14.62 M(-7.4%) | $72.87 M(+0.4%) |
June 2007 | - | $15.78 M(-38.0%) | $72.55 M(+0.8%) |
Mar 2007 | $71.82 M(-27.5%) | $25.47 M(+49.8%) | $71.97 M(+2.3%) |
Dec 2006 | - | $17.00 M(+18.9%) | $70.34 M(-25.7%) |
Sept 2006 | - | $14.30 M(-5.9%) | $94.64 M(-1.1%) |
June 2006 | - | $15.20 M(-36.3%) | $95.72 M(-3.3%) |
Mar 2006 | $99.02 M(+65.2%) | $23.84 M(-42.3%) | $99.02 M(+8.9%) |
Dec 2005 | - | $41.31 M(+168.6%) | $90.95 M(+40.0%) |
Sept 2005 | - | $15.38 M(-16.8%) | $64.94 M(+2.3%) |
June 2005 | - | $18.50 M(+17.3%) | $63.48 M(+5.9%) |
Mar 2005 | $59.94 M(+26.7%) | $15.77 M(+3.1%) | $59.94 M(-0.6%) |
Dec 2004 | - | $15.30 M(+10.0%) | $60.28 M(+2.0%) |
Sept 2004 | - | $13.91 M(-7.0%) | $59.07 M(+8.8%) |
June 2004 | - | $14.96 M(-7.1%) | $54.30 M(+14.3%) |
Mar 2004 | $47.29 M(+26.2%) | $16.11 M(+14.3%) | $47.52 M(+26.5%) |
Dec 2003 | - | $14.10 M(+54.3%) | $37.55 M(+6.4%) |
Sept 2003 | - | $9.13 M(+11.6%) | $35.28 M(-1.9%) |
June 2003 | - | $8.19 M(+33.3%) | $35.97 M(-4.0%) |
Mar 2003 | $37.48 M(-19.3%) | $6.14 M(-48.1%) | $37.48 M(-28.6%) |
Dec 2002 | - | $11.82 M(+20.3%) | $52.50 M(+20.7%) |
Sept 2002 | - | $9.83 M(+1.4%) | $43.48 M(-6.7%) |
June 2002 | - | $9.69 M(-54.2%) | $46.61 M(-26.8%) |
Mar 2002 | $46.45 M(-17.8%) | $21.16 M(+654.0%) | $63.69 M(-10.8%) |
Dec 2001 | - | $2.81 M(-78.3%) | $71.41 M(-10.3%) |
Sept 2001 | - | $12.95 M(-51.6%) | $79.57 M(+6.2%) |
June 2001 | - | $26.77 M(-7.3%) | $74.91 M(+32.8%) |
Mar 2001 | $56.52 M(+17.2%) | $28.88 M(+163.3%) | $56.42 M(+10.3%) |
Dec 2000 | - | $10.97 M(+32.3%) | $51.16 M(+4.2%) |
Sept 2000 | - | $8.29 M(-0.0%) | $49.09 M(+2.1%) |
June 2000 | - | $8.29 M(-64.9%) | $48.11 M(-0.4%) |
Mar 2000 | $48.22 M(-14.2%) | $23.62 M(+165.4%) | $48.32 M(-17.4%) |
Dec 1999 | - | $8.90 M(+21.9%) | $58.49 M(+2.8%) |
Sept 1999 | - | $7.30 M(-14.1%) | $56.89 M(-1.2%) |
June 1999 | - | $8.50 M(-74.8%) | $57.59 M(+2.1%) |
Mar 1999 | $56.19 M(+81.3%) | $33.79 M(+362.8%) | $56.39 M(+143.1%) |
Dec 1998 | - | $7.30 M(-8.8%) | $23.20 M(-11.5%) |
Sept 1998 | - | $8.00 M(+9.6%) | $26.20 M(-2.2%) |
June 1998 | - | $7.30 M(+1116.7%) | $26.80 M(-7.9%) |
Mar 1998 | $31.00 M(-41.0%) | $600.00 K(-94.2%) | $29.10 M(-33.1%) |
Dec 1997 | - | $10.30 M(+19.8%) | $43.50 M(-0.2%) |
Sept 1997 | - | $8.60 M(-10.4%) | $43.60 M(-9.0%) |
June 1997 | - | $9.60 M(-36.0%) | $47.90 M(-8.8%) |
Mar 1997 | $52.50 M(-3.3%) | $15.00 M(+44.2%) | $52.50 M(+3.6%) |
Dec 1996 | - | $10.40 M(-19.4%) | $50.70 M(-6.5%) |
Sept 1996 | - | $12.90 M(-9.2%) | $54.20 M(-1.5%) |
June 1996 | - | $14.20 M(+7.6%) | $55.00 M(+1.3%) |
Mar 1996 | $54.30 M(+3.6%) | $13.20 M(-5.0%) | $54.30 M(+0.4%) |
Dec 1995 | - | $13.90 M(+1.5%) | $54.10 M(+1.7%) |
Sept 1995 | - | $13.70 M(+1.5%) | $53.20 M(-0.2%) |
June 1995 | - | $13.50 M(+3.8%) | $53.30 M(+1.5%) |
Mar 1995 | $52.40 M(+1.2%) | $13.00 M(0.0%) | $52.50 M(-1.9%) |
Dec 1994 | - | $13.00 M(-5.8%) | $53.50 M(-1.3%) |
Sept 1994 | - | $13.80 M(+8.7%) | $54.20 M(+1.5%) |
June 1994 | - | $12.70 M(-9.3%) | $53.40 M(+3.1%) |
Mar 1994 | $51.80 M(+23.9%) | $14.00 M(+2.2%) | $51.80 M(+4.6%) |
Dec 1993 | - | $13.70 M(+5.4%) | $49.50 M(+5.3%) |
Sept 1993 | - | $13.00 M(+17.1%) | $47.00 M(+6.1%) |
June 1993 | - | $11.10 M(-5.1%) | $44.30 M(+5.5%) |
Mar 1993 | $41.80 M(+39.8%) | $11.70 M(+4.5%) | $42.00 M(+6.6%) |
Dec 1992 | - | $11.20 M(+8.7%) | $39.40 M(+9.7%) |
Sept 1992 | - | $10.30 M(+17.0%) | $35.90 M(+10.1%) |
June 1992 | - | $8.80 M(-3.3%) | $32.60 M(+9.4%) |
Mar 1992 | $29.90 M(-81.0%) | $9.10 M(+18.2%) | $29.80 M(-50.4%) |
Dec 1991 | - | $7.70 M(+10.0%) | $60.10 M(-34.5%) |
Sept 1991 | - | $7.00 M(+16.7%) | $91.70 M(-26.0%) |
June 1991 | - | $6.00 M(-84.8%) | $124.00 M(-21.2%) |
Mar 1991 | $157.30 M | $39.40 M(+0.3%) | $157.30 M(+33.4%) |
Dec 1990 | - | $39.30 M(0.0%) | $117.90 M(+50.0%) |
Sept 1990 | - | $39.30 M(0.0%) | $78.60 M(+100.0%) |
June 1990 | - | $39.30 M | $39.30 M |
FAQ
- What is Haemonetics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Haemonetics?
- What is Haemonetics annual EBIT year-on-year change?
- What is Haemonetics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Haemonetics?
- What is Haemonetics quarterly EBIT year-on-year change?
- What is Haemonetics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Haemonetics?
- What is Haemonetics TTM EBIT year-on-year change?
What is Haemonetics annual earnings before interest & taxes?
The current annual EBIT of HAE is $164.88 M
What is the all time high annual EBIT for Haemonetics?
Haemonetics all-time high annual earnings before interest & taxes is $262.10 M
What is Haemonetics annual EBIT year-on-year change?
Over the past year, HAE annual earnings before interest & taxes has changed by +$8.85 M (+5.67%)
What is Haemonetics quarterly earnings before interest & taxes?
The current quarterly EBIT of HAE is $51.70 M
What is the all time high quarterly EBIT for Haemonetics?
Haemonetics all-time high quarterly earnings before interest & taxes is $58.78 M
What is Haemonetics quarterly EBIT year-on-year change?
Over the past year, HAE quarterly earnings before interest & taxes has changed by +$16.39 M (+46.44%)
What is Haemonetics TTM earnings before interest & taxes?
The current TTM EBIT of HAE is $167.37 M
What is the all time high TTM EBIT for Haemonetics?
Haemonetics all-time high TTM earnings before interest & taxes is $178.93 M
What is Haemonetics TTM EBIT year-on-year change?
Over the past year, HAE TTM earnings before interest & taxes has changed by -$122.00 K (-0.07%)